21 CFR 201.2 - Drugs and devices; National Drug Code numbers

Cite as21 CFR 201.2
    • This document is available in original version only for vLex customers

      View this document and try vLex for 7 days
    • TRY VLEX
3 practice notes
  • Human drugs, biological products, and animal drugs; foreign and domestic establishment registration and listing requirements,
    • United States
    • Federal Register August 29, 2006
    • August 29, 2006
    ...by us (Sec. 207.35). Currently, we request, but not require, that the NDC number appear on all drug labels and labeling (Sec. 201.2 (21 CFR 201.2), Sec. 207.35(b)(3)). However, drug products described in current Sec. 201.25(b) (21 CFR 201.25(b)) must have on the label a bar code that contai......
  • Part II
    • United States
    • Federal Register August 29, 2006
    • August 29, 2006
    ...by us (Sec. 207.35). Currently, we request, but not require, that the NDC number appear on all drug labels and labeling (Sec. 201.2 (21 CFR 201.2), Sec. 207.35(b)(3)). However, drug products described in current Sec. 201.25(b) (21 CFR 201.25(b)) must have on the label a bar code that contai......
  • In re Canadian Import Antitrust Litigation, No. CIV.04-2724 JNE/JGL.
    • United States
    • United States District Courts. 8th Circuit. United States District Court of Minnesota
    • August 26, 2005
    ...the Canadian drugs are misbranded because they use a Canadian Identification Number instead of a United States National Drug Code. See 21 C.F.R. §§ 201.2, 207.35(b)(2). Plaintiffs contend, without citation to authority, that section 353(b)(2) exempts drugs dispensed by a Canadian pharmacist......
1 cases
  • In re Canadian Import Antitrust Litigation, No. CIV.04-2724 JNE/JGL.
    • United States
    • United States District Courts. 8th Circuit. United States District Court of Minnesota
    • August 26, 2005
    ...the Canadian drugs are misbranded because they use a Canadian Identification Number instead of a United States National Drug Code. See 21 C.F.R. §§ 201.2, 207.35(b)(2). Plaintiffs contend, without citation to authority, that section 353(b)(2) exempts drugs dispensed by a Canadian pharmacist......

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT